Literature DB >> 12065601

Regulation of calreticulin expression during induction of differentiation in human myeloid cells. Evidence for remodeling of the endoplasmic reticulum.

Robert A Clark1, Sen-Lin Li, Doran W Pearson, Kevin G Leidal, Joshua R Clark, Gerene M Denning, Robert Reddick, Karl-Heinz Krause, Anthony J Valente.   

Abstract

Induction of differentiation of HL-60 human myeloid cells profoundly affected expression of calreticulin, a Ca(2+)-binding endoplasmic reticulum chaperone. Induction with Me(2)SO or retinoic acid reduced levels of calreticulin protein by approximately 60% within 4 days. Pulse-chase studies indicated that labeled calreticulin decayed at similar rates in differentiated and undifferentiated cells (t(12) approximately 4.6 days), but the biosynthetic rate was <10% of control after 4 days. Differentiation also induced a rapid decline in calreticulin mRNA levels (90% reduction after 1 day) without a decrease in transcript stability (t(12) approximately 5 h). Nuclear run-on analysis demonstrated rapid down-regulation of gene transcription (21% of control at 2 h). Differentiation also greatly reduced the Ca(2+) content of the cells (25% of control), although residual Ca(2+) pools remained sensitive to thapsigargin, ionomycin, and inositol trisphosphate. Progressive decreases were also observed in levels of calnexin and ERp57, whereas BiP/GRP78 and protein disulfide isomerase were only modestly affected. Ultrastructural studies showed a substantial reduction in endoplasmic reticulum content of the cells. Thus, terminal differentiation of myeloid cells was associated with decreased endoplasmic reticulum content, selective reductions in molecular chaperones, and diminished intracellular Ca(2+) stores, perhaps reflecting an endoplasmic reticulum remodeling program as a prominent feature of granulocytic differentiation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12065601     DOI: 10.1074/jbc.M205269200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Dynamics of unfolded protein response in recombinant CHO cells.

Authors:  Kamal Prashad; Sarika Mehra
Journal:  Cytotechnology       Date:  2014-02-07       Impact factor: 2.058

2.  Non-Endoplasmic Reticulum-Based Calr (Calreticulin) Can Coordinate Heterocellular Calcium Signaling and Vascular Function.

Authors:  Lauren A Biwer; Miranda E Good; Kwangseok Hong; Rahul K Patel; Neha Agrawal; Robin Looft-Wilson; Swapnil K Sonkusare; Brant E Isakson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-11-09       Impact factor: 8.311

3.  Resistance to 1,25D-induced differentiation in human acute myeloid leukemia HL60-40AF cells is associated with reduced transcriptional activity and nuclear localization of the vitamin D receptor.

Authors:  Edward Garay; Robert Donnelly; Xuening Wang; George P Studzinski
Journal:  J Cell Physiol       Date:  2007-12       Impact factor: 6.384

4.  Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value.

Authors:  A M Vannucchi; G Rotunno; N Bartalucci; G Raugei; V Carrai; M Balliu; C Mannarelli; A Pacilli; L Calabresi; R Fjerza; L Pieri; A Bosi; R Manfredini; P Guglielmelli
Journal:  Leukemia       Date:  2014-03-12       Impact factor: 11.528

5.  Activation of the Nkx2.5-Calr-p53 signaling pathway by hyperglycemia induces cardiac remodeling and dysfunction in adult zebrafish.

Authors:  Yanyi Sun; Qiuyun Wang; Yuehua Fang; Chunfang Wu; Guoping Lu; Zhenyue Chen
Journal:  Dis Model Mech       Date:  2017-08-11       Impact factor: 5.758

6.  Platelet transcriptome identifies progressive markers and potential therapeutic targets in chronic myeloproliferative neoplasms.

Authors:  Zhu Shen; Wenfei Du; Cecelia Perkins; Lenn Fechter; Vanita Natu; Holden Maecker; Jesse Rowley; Jason Gotlib; James Zehnder; Anandi Krishnan
Journal:  Cell Rep Med       Date:  2021-10-19

7.  Calreticulin inhibits commitment to adipocyte differentiation.

Authors:  Eva Szabo; Yuanyuan Qiu; Shairaz Baksh; Marek Michalak; Michal Opas
Journal:  J Cell Biol       Date:  2008-07-07       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.